Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study
- 11 March 2005
- journal article
- pharmacoepidemiology and-prescription
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 61 (2) , 145-151
- https://doi.org/10.1007/s00228-005-0897-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Association of consultation between generalists and cardiologists with quality and outcomes of heart failure careAmerican Heart Journal, 2003
- The relevance of heart failure severity for treatment with evidence‐based pharmacotherapy in general practiceEuropean Journal of Heart Failure, 2003
- Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000Pharmacoepidemiology and Drug Safety, 2003
- Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative studyBMJ, 2003
- Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international surveyThe Lancet, 2002
- Improving Care for Patients With Chronic Heart Failure in the CommunityChest, 2002
- Team Management of Patients With Heart FailureCirculation, 2000
- Clinical governance in primary care groups: the feasibility of deriving evidence-based performance indicatorsQuality and Safety in Health Care, 2000
- Effects of Angiotensin-Converting Enzyme Inhibitors and Digoxin on Health Outcomes of Very Old Patients With Heart FailureArchives of internal medicine (1960), 2000
- Differences Between Primary Care Physicians and Cardiologists in Management of Congestive Heart Failure: Relation to Practice GuidelinesJournal of the American College of Cardiology, 1997